glp-1 sibo ACG 2025 Annual Meeting Posters Managing Gastroparesis and SIBO associated

Every treatment plan at Dynasty Clinic begins with a detailed medical assessment

Overweight or Obese Patients: NAION risks increased from 0.8% in non-semaglutide users to 6.7% among semaglutide users , representing a 590% increased absolute risk

Hyperaccumulators exhibit an unusually high uptake of HM at the root membrane level, which may be attributed to the presence of a high expression of an HM transporter in the plasma membrane (Skuza et al., 2022)

Soda versus cereal and sugar versus fat: Drivers of healthful food intake and the impact of diabetes diagnosis

Associations of socioeconomic status and healthy lifestyle with incident early-onset and late-onset dementia: A prospective cohort study